Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

October 8, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Is the pandemic interfering with the treatment for other diseases?

New Acyl CoA synthetase 4 inhibitor reduces breast and prostate tumour growth

Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer

Is the pandemic interfering with the treatment for other diseases?
  • BiotechToday
  • World

Is the pandemic interfering with the treatment for other diseases?

bioxone October 19, 2020October 19, 2020

Camelia Bhattacharyya, Amity University Kolkata

The pandemic, that is, the COVID-19 pandemic hit the world all of a sudden, changing infection rates or rather increasing it every day without leaving the world to think of the ways to fight with the unknown enemy, the virus. This created a lot of panic at the beginning of the year (2020) since the healthcare system were neither aware of the ways to deal with the patients infected by the virus,  nor were there enough beds to accommodate such a huge number of patients. Recently, the new normal has led to a lot of changes in this area and the situation can now be controlled in a better way, thus resulting in a decrease in the infection rate per day.

The examination of the datasets maintained by the National Health Service (NHS) showed the signs of a quick adaptation of the system, cancelling elective surgeries, dividing departments for general and acute (G&A) patients and critical care (CC) patients while also deciding on the staffs, beds, ventilators and other stuff based on such needs. Newly qualified medicals staffs are recruited, private hospitals are also involved in the service for the selfless treatments of the patients. All these have resulted in fewer deaths due to the pandemic while putting the entire system go through a basic question: is the system capable enough to deal with other diseases along with the virus at the same time? The answer is quite controversial. In England, it has been noted that the number of patients can be maintained only when the number of COVID patients is 1550 daily. In other words, the healthcare professionals will ignore the other disease requiring urgent attention if the number of patients of COVID-19 goes out of control. 

This might lead to more deaths due to all other diseases than due to the pandemic. Thus, better planning and a proper system are required to maintain a balance and to avoid biases coming in the way of treating patients.

Also read: A Paradigm unleashes to target Ovarian Carcinoma

Source:
Might read: McCabe, R., Schmit, N., Christen, P. et al. Adapting hospital capacity to meet changing demands during the COVID-19 pandemic. BMC Med 18,329 (2020). https://doi.org/10.1186/s12916-020-01781-w

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged CC CDC COVID-19 elective surgeries G&A healthcare healthcare system hospitals infection Medicine NHS NIH pandemic patients SARS-CoV-2 Social treatment UK USA WHO World

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Disruption of mutp53 stability might hold the key in this long and hard battle against Cancer

bioxone October 20, 2020

Biswadeep Sen, Amity University Kolkata Recent studies show that Inflammation and Carcinogenic processes are interconnected. Not just because both induce DNA instability, but both are driven by the same pathways (like NF-kB, STAT3, mTOR and MAPKs).  The pro-inflammatory cytokines like IL-6, IL-1β, TNF-α and IL-10 mould our immune responses and they are controlled by the […]

mutp53

Related Post

  • BiotechToday
  • World

Chronic Fatigue Syndrome: Post-exertional Malaise studies

bioxone September 28, 2020September 28, 2020

BISWADEEP SEN, AMITY UNIVERSITY KOLKATA Persistent fatigue, increasing exercise intolerance, cognitive difficulties, or joint pain are the main symptoms of Post-exertional malaise. It is the pivotal reason for ME /Chronic Fatigue Syndrome. 43 patients were subjected to a Cardiopulmonary exercise test and the data was categorized systematically for analysis. In CPET, the patients have to […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Recent insights into the role of Ubiquitination

BioTech Today July 2, 2021July 1, 2021

Sumedha B S, Bangalore University What is Ubiquitin? Ubiquitin is a small 76-amino acid protein found in eukaryotic cells. They are be found either freely or covalently bound to membrane proteins. It is one of the highly conserved proteins. This means its amino acid sequence is similar-from yeast to animals. It has two functional sites: […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Ion Identity Molecular Networking (IIMN)

bioxone June 25, 2021June 24, 2021

Hari Krishnan R, SRM Institute of Science and Technology Ion Identity Molecular Networking (IIMN) connects and collapses ion species of the same molecule. Ionization by mass spectrometry causes molecules to form multiple ion species expressing different fragmentation patterns, this causes the formation of redundant and disconnected sub-networks of the same compound species. IIMN is a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy